Announcement on behalf of subsidiary, Applied BioCode, Inc., signed an amended license and supply agreement with IDEXX Technologies GmbH
· Issued by Applied BioCode Corp.
Close
Today's Information
Provided by: Applied BioCode Corporation
SEQ_NO
1
Date of announcement
2022/05/27
Time of announcement
14:41:28
Subject
Announcement on behalf of subsidiary,
Applied BioCode, Inc., signed an amended license and
supply agreement with IDEXX Technologies GmbH
Date of events
2022/05/27
To which item it meets
paragraph 10
Statement
1.Date of occurrence of the event:2022/05/27
2.Counterparty to the contract or commitment:
IDEXX Technologies GmbH
3.Relationship with the Company:None.
4.Starting and ending dates (or rescission date) of the
contract or commitment:2022/05/12~2032/12/31
5.Major content (not applicable where rescinded):
IDEXX Technologies GmbH is authorized partially manufacturing process
of BMB to customize detection platform in non-human diagnostic area by
subsidiary of ABC-KY(Stock Code:6598), Applied BioCode,Inc.
6.Restrictive covenants (not applicable where rescinded):confidential terms.
7.Commitment (not applicable where rescinded):confidential terms.
8.Any other important agreement (not applicable where rescinded):
confidential terms.
9.Effect on company finances and business:
The payment paid by IDEXX Technologies GmbH to the subsidiary of
ABC-KY(Stock Code:6598), Applied BioCode,Inc.
(1)Royalty: Approximately USD 12,000,000, to be paid completely
in three installments.
(2)Wafer purchase: Purchase price is following the terms in the agreement.
IDEXX Technologies GmbH purchases wafers with proprietary technology
of ABC-KY depends on its demand.
(3)Other products purchase: IDEXX Technologies GmbH will keep purchasing
scanner and BMB depends on its demand.
10.Concrete purpose/objective:To deepen the Company's cooperation with
IDEXX Technologies GmbH, and increase application proportion of the
Company's technology inside IDEXX Technologies GmbH.
11.Any other matters that need to be specified:None.
